glp-1 receptor agonists should be avoided in patients with MYTH BUSTER #1 “Weight-loss injections like medicines are not safe.” Is this really true? GLP-1 (such as Ozempic®) are among the most discussed anti-obesity medicines today. Unfortunately, misinformation on Ten Top Tips for the

During the preparation of this work the authors used Perplexity Pro in order to optimize clarity, tone, and academic rigor and to polish the paper

Their appeal lies in their holistic nature

Ending last week, its up 42.7% - certainly not the end of the world (although the reaction to LLY and NVOs drawdown would have you thinking it was)

When oxidative throughput approaches or exceeds regenerative redox-buffering capacity under constrained substrate inflow, a rate-limiting metabolic state can be conceptualizedreferred to here as a redox bottleneck as discussed in Sect

European Society of Cardiology (ESC)

The breakthrough obesity drugs that have stunned researchers